Jia Jie Biomedical Co Ltd Cash Flow Quality Index
Jia Jie Biomedical Co Ltd cash flow quality index. Jia Jie Biomedical Co Ltd (4109) has a Cash Flow Quality Index of 0.70x as of March 2026. Operating cash flow of NT$12.96 Million is below net income of NT$18.40 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Jia Jie Biomedical Co Ltd cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Jia Jie Biomedical Co Ltd (2015–2025)
Cash flow quality index of Jia Jie Biomedical Co Ltd from 2015 to 2025. Historical Cash Flow Quality Index for Jia Jie Biomedical Co Ltd across 7 annual periods. Values consistently above 1.0x indicate high-quality earnings. See 4109 net asset quality index to measure how much of total assets are equity-financed.
Jia Jie Biomedical Co Ltd Cash Flow Quality Index by Year (2015–2025)
Jia Jie Biomedical Co Ltd cash flow quality index by year from 2015 to 2025. Year-by-year earnings quality comparison for Jia Jie Biomedical Co Ltd. For the full cash flow conversion analysis, see Jia Jie Biomedical Co Ltd (4109) cash conversion ratio.
| Year | Quality Index | Operating CF (TWD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.42x | NT$21.34 Million | NT$50.26 Million | ▲ +102.4% |
| 2024 | 0.21x | NT$44.35 Million | NT$211.37 Million | ▲ +785.1% |
| 2023 | -0.03x | NT$-4.49 Million | NT$146.55 Million | ▼ -103.7% |
| 2021 | 0.83x | NT$4.37 Million | NT$5.29 Million | ▲ +115.6% |
| 2018 | -5.29x | NT$-13.10 Million | NT$2.47 Million | ▲ +19.6% |
| 2016 | -6.58x | NT$-76.54 Million | NT$11.63 Million | ▼ -402.9% |
| 2015 | 2.17x | NT$82.22 Million | NT$37.84 Million | — |